Phaim Pharma Ltd

Phaim Pharma Ltd

Biotechnology

London, England 828 followers

Our vision is to create a world where no one has to live with an autoimmune disease.

About us

We are a London-based biotechnology company developing a novel therapeutic platform, known as Antigenic Immune Modulation (AIM), designed to cure, improve, halt or prevent autoimmune disease. Our lead drug candidate targets Type 1 Diabetes (T1D), with a pipeline that includes psoriasis, rheumatoid arthritis, and multiple sclerosis. We are committed to transforming the lives of those affected by autoimmune disease and delivering life-changing therapies.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
London, England
Type
Privately Held
Founded
2014

Locations

Employees at Phaim Pharma Ltd

Updates

Similar pages